Intoxicating hemp could snarl government funding
Presented by Coalition to Strengthen America’s Healthcare {beacon} Healthcare Healthcare The Big Story Intoxicating hemp could snarl government funding A pair of GOP senators say they won’t support any government funding bill if it includes language that delays or reverses the recriminalization of intoxicating hemp products. © AP Photo/Markus Schreiber After bipartisan legislation was introduced…
Intoxicating hemp could snarl government funding
A pair of GOP senators say they won’t support any government funding bill if it includes language that delays or reverses the recriminalization of intoxicating hemp products .
After bipartisan legislation was introduced in the Senate to establish a comprehensive federal regulatory framework for hemp, Sens. Ted Budd (R-N.C.) and Pete Ricketts (R-Neb.) strongly objected. In separate social media posts, each said they would not support a government funding bill that overturns a looming ban on most hemp-derived THC products.
“I will not support any year-end package that extends, delays, or builds a regulatory framework around products that fuel addiction, endanger our children, and weaken our workforce,” Budd wrote on X. “Congress closed the hemp loophole more than a year ago to end an industry that never should have existed.”
Budd was responding to a bill introduced this week by Sens. Tim Sheehy (R-Mont.) and Amy Klobuchar (D-Minn.) that would set up a new regulatory framework for hemp products. Among other provisions, it would bar sales of consumable hemp products to people under 21, raise the legal threshold for THC-containing hemp, and ban “gas station” marijuana products derived from hemp.
The legislation’s timing is important. Beginning Dec. 11 , the federal definition of hemp will change to close what critics called the “hemp loophole” brought about by the 2018 Farm Bill, which removed hemp from the controlled substances list.
Without action, hemp industry advocates say their multi-billion-dollar industry could collapse.
Internal Republican disagreements over the issue complicated passage of last funding bill, after a provision delaying the ban for a month was inserted into the legislation. Budd and other senators tried unsuccessfully to get the delay language removed from the bill that Trump most recently signed and are gearing up to try again.
Hemp industry groups and their allies have been lobbying lawmakers to regulate their products, rather than ban them.
“I won’t support any legislation that allows these drugs to continue hurting our kids and communities,” he wrote.
Welcome to The Hill’s Healthcare newsletter , we’re Nathaniel Weixel and Joseph Choi — every week we follow the latest moves on how Washington impacts your health.
Did someone forward you this newsletter? Subscribe here.
How policy will be impacting the healthcare sector this week and beyond:
Senate Republicans are set to lose eight members in January, and a few of them are not going easy. These members have become occasional critics of the administration, more willing to hold up President Trump’s agenda or personnel when they see a need for it. The pattern reflects the major loss Trump took in the midterm elections, as blind loyalty to the president was generally a vulnerability for Republicans. …
FORT LAUDERDALE, Fla. (WFLA) — Nearly 150 people aboard a cruise ship have been sickened by an “unknown” gastrointestinal illness outbreak, according to the Centers for Disease Control and Prevention (CDC). The outbreak was first reported on the Caribbean Princess ship on Sunday, Nov. 15. The ship departed from Fort Lauderdale on Nov. 11. The CDC said 134 passengers and 14 crew members have reported symptoms. …
A key Senate committee rejected the Trump administration’s pick to lead the National Science Foundation (NSF), just hours after the White House decided to withdraw its nominee to lead the Food and Drug Administration. Sen. Bill Cassidy (R-La.), chair of the Senate Health, Education, Labor and Pensions Committee, on Wednesday said Jim O’Neill, who previously served as acting director of the Centers for Disease Control and Prevention …
Branch out with a different read from The Hill:
NIH to move remaining retired research chimps to sanctuary
The National Institutes of Health (NIH) announced Wednesday it will release the last government-owned research chimpanzees in early 2027 to a sanctuary, ending a decade-long effort to retire the rest of the chimps held at NIH-supported animal care facilities. The 34 chimpanzees, currently housed at the Keeling Center for Comparative Medicine and Research in Bastrop, Texas, will be transferred to Chimp Haven, a 200-acre Louisiana …
Local and state headlines on healthcare:
Indiana won’t implement Medicaid work requirement grace period ( Indiana Capital Chronicle )
Deputy Health Secretary Briskin stepping down in December, as state braces for Medicaid changes ( Maryland Matters )
Ken Paxton drops out of doctor’s lawsuit against the Texas Medical Board ( The Texas Tribune )
Health news we’ve flagged from other outlets:
Sudden withdrawal of Trump’s FDA pick blindsided officials and left key senator fuming, sources say ( CNN )
Before midterm losses, MAHA spent on itself instead of candidates ( Stat )
A Medicare rule change could turn one visit to the doctor into two ( NBC )
Opinions related to health submitted to The Hill:
Check out The Hill’s Healthcare page for the latest coverage.
400 N Capitol Street NW Suite 650, Washington, DC 20001
If you believe this has been sent to you in error, please safely unsubscribe .
Topics in this story
Gathered from external sources. Rights to this text belong to whoever originally published it.